[Results of immunoprophylaxis of HIV-infected patients with 13-valent conjugated pneumococcal vaccine].
A V ZhestkovM O ZolotovA V LyaminO V BorisovaO E ChernovaE A ZheleznovaDanir Damirovich IsmatullinPublished in: Terapevticheskii arkhiv (2021)
Thus, immunoprophylaxis with PCV13 in adult HIV-infected patients leads to a decrease in the carriage of S. pneumoniae, and also promotes the stimulation of the T-cell link of the immune system and stimulates the formation of immunological memory cells.